{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:31:58Z","timestamp":1777638718232,"version":"3.51.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1082","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Budd\u2013Chiari syndrome is a rare disorder characterised by hepatic venous outflow obstruction. It affects 1.4 per million people, and presentation depends upon the extent and rapidity of hepatic vein occlusion. An underlying myeloproliferative neoplasm is present in 50% of cases with other causes including infection and malignancy. Common symptoms are abdominal pain, hepatomegaly and ascites; however, up to 20% of cases are asymptomatic, indicating a chronic onset of hepatic venous obstruction and the formation of large hepatic vein collaterals. Doppler ultrasonography usually confirms diagnosis with cross-sectional imaging used for complex cases and to allow temporal comparison. Myeloproliferative neoplasms should be tested for even if a clear causative factor has been identified. Management focuses on anticoagulation with low-molecular-weight heparin and warfarin, with the new oral anticoagulants offering an exciting prospect for the future, but their current effectiveness in Budd\u2013Chiari syndrome is unknown. A third of patients require further intervention in addition to anticoagulation, commonly due to deteriorating liver function or patients identified as having a poorer prognosis. Prognostic scoring systems help guide treatment, but management is complex and patients should be referred to a specialist liver centre. Recent studies have shown comparable procedure-related complications and long-term survival in patients who undergo transjugular intrahepatic portosystemic shunting and liver transplantation in Budd\u2013Chiari syndrome compared with other liver disease aetiologies. Also, the optimal timing of these interventions and which patients benefit from liver transplantation instead of portosystemic shunting remains to be answered.<\/jats:p>","DOI":"10.1136\/postgradmedj-2015-133402","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T02:43:36Z","timestamp":1445568216000},"page":"692-697","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Budd\u2013Chiari syndrome: investigation, treatment and outcomes"],"prefix":"10.1093","volume":"91","author":[{"given":"Rishi M","family":"Goel","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 Hospitals NHS Foundation Trust , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 Hospitals NHS Foundation Trust , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal V","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 Hospitals NHS Foundation Trust , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Guy\u2019s and St Thomas\u2019 Hospitals NHS Foundation Trust , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"key":"2023041905524021900_R1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Pleisser","year":"2006","journal-title":"Hepatology"},{"key":"2023041905524021900_R2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1478-3231.2008.01838.x","article-title":"Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival\u2014an 18-year experience","volume":"29","author":"Rajani","year":"2009","journal-title":"Liver Int"},{"key":"2023041905524021900_R3","volume-title":"Sleisenger and Fordtran's gastrointestinal and liver disease","author":"Feldman","year":"2010","edition":"9th edn"},{"key":"2023041905524021900_R4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatology"},{"key":"2023041905524021900_R5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2008.10.007","article-title":"Primary Budd-Chiari syndrome","volume":"50","author":"Valla","year":"2009","journal-title":"J Hepatol"},{"key":"2023041905524021900_R6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"Deleve","year":"2009","journal-title":"Hepatology"},{"key":"2023041905524021900_R7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.510280505","article-title":"Proposal of a new nomenclature for Budd-Chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion","volume":"28","author":"Okuda","year":"1998","journal-title":"Hepatology"},{"key":"2023041905524021900_R8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4254\/wjh.v7.i6.874","article-title":"Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of the inferior vena cava)","volume":"7","author":"Shrestha","year":"2015","journal-title":"World J Hepatol"},{"key":"2023041905524021900_R9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.qjmed.a030135","article-title":"Clinical spectrum, investigations, and treatment of Budd-Chiari syndrome","volume":"89","author":"Mahmoud","year":"1996","journal-title":"QJM"},{"key":"2023041905524021900_R10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0272-6386(98)70032-0","article-title":"Budd-Chiari syndrome during nephrotic relapse in a patient with resistance to activated protein C clotting inhibitor","volume":"32","author":"Gambarro","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"2023041905524021900_R11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0016-5085(94)90765-X","article-title":"The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases","volume":"106","author":"Hadengue","year":"1994","journal-title":"Gastroenterology"},{"key":"2023041905524021900_R12","first-page":"282","volume-title":"Progress in liver diseases","author":"Trey","year":"1970","edition":"3rd edn"},{"key":"2023041905524021900_R13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/0016-5085(91)70020-X","article-title":"Diagnosis of Budd-Chiari syndrome by pulsed Doppler ultrasound","volume":"100","author":"Bolondi","year":"1991","journal-title":"Gastroenterology"},{"key":"2023041905524021900_R14","volume-title":"GI\/Liver secrets","author":"McNally","year":"2006","edition":"3rd edn"},{"key":"2023041905524021900_R15","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg","year":"2012","journal-title":"Blood"},{"key":"2023041905524021900_R16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5152\/tjg.2015.5738","article-title":"Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and\/or portal vein thrombosis","volume":"26","author":"Karak\u00f6se","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"2023041905524021900_R17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2014.08.032","article-title":"Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis","volume":"62","author":"Turon","year":"2015","journal-title":"J Hepatol"},{"key":"2023041905524021900_R18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organisation (WHO) classification of myeloid neoplasms and acute leukaemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"2023041905524021900_R19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.20064","article-title":"Determinants of survival and the effect portosystemic shunting in patients with Budd-Chiari syndrome","volume":"39","author":"Murad","year":"2004","journal-title":"Hepatology"},{"key":"2023041905524021900_R20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pag\u00e1n","year":"2008","journal-title":"Gastroenterology"},{"key":"2023041905524021900_R21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0168-8278(03)00323-4","article-title":"Clinicopathological forms and prognostic index in Budd-Chiari syndrome","volume":"39","author":"Langlet","year":"2003","journal-title":"J Hepatol"},{"key":"2023041905524021900_R22","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"2023041905524021900_R23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1365-2036.2009.04134.x","article-title":"Rotterdam score predicts early mortality in Budd-Chiari syndrome, and surgical shunting prolongs transplant-free survival","volume":"30","author":"Montano-Loza","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905524021900_R24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"2023041905524021900_R25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MEG.0b013e32835eb8d4","article-title":"Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review","volume":"25","author":"Ren","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023041905524021900_R26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2141.2005.05490.x","article-title":"Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis","volume":"129","author":"Chait","year":"2005","journal-title":"Br J Haematol"},{"key":"2023041905524021900_R27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythaemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"2023041905524021900_R28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2003.09.028","article-title":"Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre experience and review of the literature","volume":"40","author":"Sharma","year":"2004","journal-title":"J Hepatol"},{"key":"2023041905524021900_R29","first-page":"334","article-title":"Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome","volume":"66","author":"Hoekstra","year":"2008","journal-title":"Neth J Med"},{"key":"2023041905524021900_R30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11239-012-0760-4","article-title":"Systemic thrombolysis for acute, severe Budd-Chiari syndrome","volume":"34","author":"Clark","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"2023041905524021900_R31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.44.4.568","article-title":"Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting","volume":"44","author":"Fisher","year":"1999","journal-title":"Gut"},{"key":"2023041905524021900_R32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.12668","article-title":"Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome","volume":"39","author":"Tripathi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2023041905524021900_R33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, Management, and Outcome of the Budd-Chiari Syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023041905524021900_R34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/00365521.2013.777775","article-title":"Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures","volume":"48","author":"Qi","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"2023041905524021900_R35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2006.08.016","article-title":"Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome","volume":"46","author":"Bachet","year":"2007","journal-title":"J Hepatol"},{"key":"2023041905524021900_R36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/hep.20436","article-title":"PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome","volume":"40","author":"Hern\u00e1ndez-Guerra","year":"2004","journal-title":"Hepatology"},{"key":"2023041905524021900_R37","first-page":"155","article-title":"Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome?","volume":"65","author":"Langlet","year":"2002","journal-title":"Acta Gastro-Enterologica Belgica"},{"key":"2023041905524021900_R38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12659\/AOT.882630","article-title":"Results of liver transplantation in the treatment of Budd-Chiari syndrome","volume":"17","author":"Mackiewicz","year":"2012","journal-title":"Ann Transplant"},{"key":"2023041905524021900_R39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2005.12.002","article-title":"Liver transplantation for Budd-Chiari syndrome: a European study on 248 patients from 51 centres","volume":"44","author":"Mentha","year":"2006","journal-title":"J Hepatol"},{"key":"2023041905524021900_R40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00007890-200210270-00006","article-title":"Haematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders","volume":"74","author":"Melear","year":"2002","journal-title":"Transplantation"},{"key":"2023041905524021900_R41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1432-2277.2003.tb00260.x","article-title":"Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal haemoglobinuria","volume":"16","author":"Bahr","year":"2003","journal-title":"Transpl Int"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/91\/1082\/692\/49967171\/postgradmedj-91-692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/91\/1082\/692\/49967171\/postgradmedj-91-692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T05:53:32Z","timestamp":1681883612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/91\/1082\/692\/6994959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":41,"journal-issue":{"issue":"1082","published-online":{"date-parts":[[2015,10,22]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2015-133402","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,12]]},"published":{"date-parts":[[2015,10,22]]}}}